Viraemic frequencies and seroprevalence of non-primate hepacivirus and equine pegiviruses in horses and other mammalian species

Journal of General Virology

Volumn 95, Issue PART 8, 2014, Pages 1701-1711

  Lyons, Sinéad ^a   Kapoor, Amit ^b   Schneider, Bradley S ^c   Wolfe, Nathan D ^c   Culshaw, Geoff ^a   Corcoran, Brendan ^a   Durham, Andy E ^d   Burden, Faith ^e   McGorum, Bruce C ^a   Simmonds, Peter ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Department of Medicine   (United States)

^c METABIOTA INC   (United States)

^d LIPHOOK EQUINE HOSPITAL   (United Kingdom)

^e THE DONKEY SANCTUARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS RNA;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOG; DONKEY; EQUINE PEGIVIRUS; HEPATITIS C VIRUS; HORSE; HUMAN; LIVER DISEASE; MAMMAL; NONHUMAN; NONPRIMATE HEPACIVIRUS; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; SEROPREVALENCE; VIRAL CLEARANCE; VIREMIA; VIRUS DETECTION; VIRUS INFECTION; VIRUS LOAD;

ANIMALS; ANTIBODIES, VIRAL; DOG DISEASES; DOGS; FLAVIVIRIDAE; FLAVIVIRIDAE INFECTIONS; FLAVIVIRUS INFECTIONS; HORSE DISEASES; HORSES; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; SEROEPIDEMIOLOGIC STUDIES; VIREMIA;

EID: 84904429749     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.065094-0     Document Type: Article

References (58)

1. Adams, N. J., Prescott, L. E., Jarvis, L. M., Lewis, J. C., McClure, M. O., Smith, D. B. & Simmonds, P. (1998). Detection in chimpanzees of a novel flavivirus related to GB virus-C/hepatitis G virus. J Gen Virol 79, 1871-1877.
2. Alberti, A., Morsica, G., Chemello, L., Cavalletto, D., Noventa, F., Pontisso, P. & Ruol, A. (1992). Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 340, 697-698.
3. Alter, H. J., Sanchez-Pescador, R., Urdea, M. S., Wilber, J. C., Lagier, R. J., Di Bisceglie, A. M., Shih, J. W. & Neuwald, P. D. (1995). Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA. J Viral Hepat 2, 121-132.
4. Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A. & Margolis, H. S. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341, 556-562.
5. Averhoff, F. M., Glass, N. & Holtzman, D. (2012). Global burden of hepatitis C: considerations for healthcare providers in the United States. Clin Infect Dis 55 (Suppl 1), S10-S15.
6. Berg, T., Müller, A. R., Platz, K. P., Höhne, M., Bechstein, W. O., Hopf, U., Wiedenmann, B., Neuhaus, P. & Schreier, E. (1999). Dynamics of GB virus C viremia early after orthotopic liver transplantation indicates extrahepatic tissues as the predominant site of GB virus C replication. Hepatology 29, 245-249.
7. Birkenmeyer, L. G., Desai, S. M., Muerhoff, A. S., Leary, T. P., Simons, J. N., Montes, C. C. & Mushahwar, I. K. (1998). Isolation of a GB virus-related genome from a chimpanzee. J Med Virol 56, 44-51.
8. Blair, C. S., Davidson, F., Lycett, C., McDonald, D. M., Haydon, G. H., Yap, P. L., Hayes, P. C., Simmonds, P. & Gillon, J. (1998). Prevalence, incidence, and clinical characteristics of hepatitis G virus/ GB virus C infection in Scottish blood donors. J Infect Dis 178, 1779-1782.
9. Bukh, J., Apgar, C. L., Govindarajan, S. & Purcell, R. H. (2001). Host range studies of GB virus-B hepatitis agent, the closest relative of hepatitis C virus, in New World monkeys and chimpanzees. J Med Virol 65, 694-697.
10. Burbelo, P. D., Dubovi, E. J., Simmonds, P., Medina, J. L., Henriquez, J. A., Mishra, N., Wagner, J., Tokarz, R., Cullen, J. M. & other authors (2012). Serology-enabled discovery of genetically diverse hepaciviruses in a new host. J Virol 86, 6171-6178.
11. Chandriani, S., Skewes-Cox, P., Zhong, W., Ganem, D. E., Divers, T. J., Van Blaricum, A. J., Tennant, B. C. & Kistler, A. L. (2013). Identification of a previously undescribed divergent virus from the Flaviviridae family in an outbreak of equine serum hepatitis. Proc Natl Acad Sci U S A 110, E1407-E1415.
12. Crofts, N. & Aitken, C. K. (1997). Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995. Med J Aust 167, 17-20.
13. Drexler, J. F., Corman, V. M., Müller, M. A., Lukashev, A. N., Gmyl, A., Coutard, B., Adam, A., Ritz, D., Leijten, L. M. & other authors (2013). Evidence for novel hepaciviruses in rodents. PLoS Pathog 9, e1003438.
14. Engel, M., Malta, F. M., Gomes, M. M., Mello, I. M., Pinho, J. R., Ono-Nita, S. K. & Carrilho, F. J. (2007). Acute hepatitis C virus infection assessment among chronic hemodialysis patients in the Southwest Parana State, Brazil. BMC Public Health 7, 50.
15. Epstein, J. H., Quan, P. L., Briese, T., Street, C., Jabado, O., Conlan, S., Ali Khan, S., Verdugo, D., Hossain, M. J. & other authors (2010). Identification of GBV-D, a novel GB-like flavivirus from Old World frugivorous bats (Pteropus giganteus) in Bangladesh. PLoS Pathog 6, e1000972.
16. Fierer, D. S., Uriel, A. J., Carriero, D. C., Klepper, A., Dieterich, D. T., Mullen, M. P., Thung, S. N., Fiel, M. I. & Branch, A. D. (2008). Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study. J Infect Dis 198, 683-686.
17. Gómara, M. J., Fernández, L., Pérez, T., Ercilla, G. & Haro, I. (2010). Assessment of synthetic chimeric multiple antigenic peptides for diagnosis of GB virus C infection. Anal Biochem 396, 51-58.
18. Gutierrez, R. A., Dawson, G. J., Knigge, M. F., Melvin, S. L., Heynen, C. A., Kyrk, C. R., Young, C. E., Carrick, R. J., Schlauder, G. G. & other authors (1997). Seroprevalence of GB virus C and persistence of RNA and antibody. J Med Virol 53, 167-173.
19. Kapoor, A., Simmonds, P., Gerold, G., Qaisar, N., Jain, K., Henriquez, J. A., Firth, C., Hirschberg, D. L., Rice, C. M. & other authors (2011). Characterization of a canine homolog of hepatitis C virus. Proc Natl Acad Sci U S A 108, 11608-11613.
20. Kapoor, A., Simmonds, P., Cullen, J. M., Scheel, T. K., Medina, J. L., Giannitti, F., Nishiuchi, E., Brock, K. V., Burbelo, P. D. & other authors (2013a). Identification of a pegivirus (GB virus-like virus) that infects horses. J Virol 87, 7185-7190.
21. Kapoor, A., Simmonds, P., Scheel, T. K. H., Hjelle, B., Cullen, J. M., Burbelo, P. D., Chauhan, L. V., Duraisamy, R., Sanchez Leon, M. & other authors (2013b). Identification of rodent homologs of hepatitis C virus and pegiviruses. MBio 4, e00216-e13.
22. King, A. M., Adams, M. J., Lefkowitz, E. J. & Carstens, E. B. (2011). Virus taxonomy: IXth report of the International Committee on Taxonomy of Viruses: Access Online via Elsevier.
23. Lauck, M., Sibley, S. D., Lara, J., Purdy, M. A., Khudyakov, Y., Hyeroba, D., Tumukunde, A., Weny, G., Switzer, W. M. & other authors (2013). A novel hepacivirus with an unusually long and intrinsically disordered NS5A protein in a wild Old World primate. J Virol 87, 8971-8981.
24. Lavoie, M., Sharp, C. P., Pépin, J., Pennington, C., Foupouapouognigni, Y., Pybus, O. G., Njouom, R. & Simmonds, P. (2012). Human parvovirus 4 infection, Cameroon. Emerg Infect Dis 18, 680-683.
25. Lyons, S., Kapoor, A., Sharp, C., Schneider, B. S., Wolfe, N. D., Culshaw, G., Corcoran, B., McGorum, B. C. & Simmonds, P. (2012). Nonprimate hepaciviruses in domestic horses, United Kingdom. Emerg Infect Dis 18, 1976-1982.
26. Mathurin, P., Moussalli, J., Cadranel, J. F., Thibault, V., Charlotte, F., Dumouchel, P., Cazier, A., Huraux, J. M., Devergie, B. & other authors (1998). Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. Hepatology 27, 868-872.
27. Miller, F. D. & Abu-Raddad, L. J. (2010). Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc Natl Acad Sci U S A 107, 14757-14762.
28. Mohr, E. L. & Stapleton, J. T. (2009). GB virus type C interactions with HIV: the role of envelope glycoproteins. J Viral Hepat 16, 757-768.
29. Muerhoff, A. S., Leary, T. P., Simons, J. N., Pilot-Matias, T. J., Dawson, G. J., Erker, J. C., Chalmers, M. L., Schlauder, G. G., Desai, S. M. & Mushahwar, I. K. (1995). Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis. J Virol 69, 5621-5630.
30. Nalpas, B., Thiers, V., Pol, S., Driss, F., Thepot, V., Berthelot, P. & Brechot, C. (1992). Hepatitis C viremia and anti-HCV antibodies in alcoholics. J Hepatol 14, 381-384.
31. Pavlova, B. G., Heinz, R., Selim, U., Tüchler, H., Pittermann, E. & Eder, G. (1999). Association of GB virus C (GBV-C)/hepatitis G virus (HGV) with haematological diseases of different malignant potential. J Med Virol 57, 361-366.
32. Perz, J. F., Farrington, L. A., Pecoraro, C., Hutin, Y. J. & Armstrong, G. L. (2004). Estimated global prevalence of hepatitis C virus infection. 42nd Annual Meeting of the Infectious Diseases Society of America. Boston, MA, USA.
33. Pilot-Matias, T. J., Carrick, R. J., Coleman, P. F., Leary, T. P., Surowy, T. K., Simons, J. N., Muerhoff, A. S., Buijk, S. L., Chalmers, M. L. & other authors (1996a). Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker. Virology 225, 282-292.
34. Pilot-Matias, T. J., Muerhoff, A. S., Simons, J. N., Leary, T. P., Buijk, S. L., Chalmers, M. L., Erker, J. C., Dawson, G. J., Desai, S. M. & Mushahwar, I. K. (1996b). Identification of antigenic regions in the GB hepatitis viruses GBV-A, GBV-B, and GBV-C. J Med Virol 48, 329-338.
35. Polgreen, P. M., Xiang, J., Chang, Q. & Stapleton, J. T. (2003). GB virus type C/hepatitis G virus: a non-pathogenic flavivirus associated with prolonged survival in HIV-infected individuals. Microbes Infect 5, 1255-1261.
36. Pradat, P., Alberti, A., Poynard, T., Esteban, J. I., Weiland, O., Marcellin, P., Badalamenti, S. & Tré po, C. (2002). Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study. Hepatology 36, 973-977.
37. Puoti, C. (2003). HCV carriers with persistently normal aminotransferase levels: normal does not always mean healthy. J Hepatol 38, 529-532.
38. Puoti, C., Magrini, A., Stati, T., Rigato, P., Montagnese, F., Rossi, P., Aldegheri, L. & Resta, S. (1997). Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels. Hepatology 26, 1393-1398.
39. Quan, P. L., Firth, C., Conte, J. M., Williams, S. H., Zambrana-Torrelio, C. M., Anthony, S. J., Ellison, J. A., Gilbert, A. T., Kuzmin, I. V. & other authors (2013). Bats are a major natural reservoir for hepaciviruses and pegiviruses. Proc Natl Acad Sci U S A 110, 8194-8199.
40. Qureshi, H., Bile, K. M., Jooma, R., Alam, S. E. & Afridi, H. U. (2010). Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. East Mediterr Health J 16 (Suppl), S15-S23.
41. Scallan, M. F., Clutterbuck, D., Jarvis, L. M., Scott, G. R. & Simmonds, P. (1998). Sexual transmission of GB virus C/hepatitis G virus. J Med Virol 55, 203-208.
42. Schwarze-Zander, C., Blackard, J. T., Zheng, H., Addo, M. M., Lin, W., Robbins, G. K., Sherman, K. E., Zdunek, D., Hess, G., Chung, R. T. & AIDS Clinical Trial Group A5071 Study Team (2006). GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. J Infect Dis 194, 410-419.
43. Sharp, P. M. & Simmonds, P. (2011). Evaluating the evidence for virus/host co-evolution. Curr Opin Virol 1, 436-441.
44. Sharp, C. P., LeBreton, M., Kantola, K., Nana, A., Diffo, Jle. D., Djoko, C. F., Tamoufe, U., Kiyang, J. A., Babila, T. G. & other authors (2010). Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild. J Virol 84, 10289-10296.
45. Shepard, C. W., Finelli, L. & Alter, M. J. (2005). Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5, 558-567.
46. Simmonds, P. (2012). SSE: a nucleotide and amino acid sequence analysis platform. BMC Res Notes 5, 50.
47. Simmonds, P. (2013). The origin of hepatitis C virus. Curr Top Microbiol Immunol 369, 1-15.
48. Simons, J. N., Leary, T. P., Dawson, G. J., Pilot-Matias, T. J., Muerhoff, A. S., Schlauder, G. G., Desai, S. M. & Mushahwar, I. K. (1995a). Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1, 564-569.
49. Simons, J. N., Pilot-Matias, T. J., Leary, T. P., Dawson, G. J., Desai, S. M., Schlauder, G. G., Muerhoff, A. S., Erker, J. C., Buijk, S. L. & other authors (1995b). Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci U S A 92, 3401-3405.
50. Stapleton, J. T., Foung, S., Muerhoff, A. S., Bukh, J. & Simmonds, P. (2011). The GB viruses: a review and proposed classification of GBVA, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. J Gen Virol 92, 233-246.
51. Sugitani, M., Inchauspé, G., Shindo, M. & Prince, A. M. (1992). Sensitivity of serological assays to identify blood donors with hepatitis C viraemia. Lancet 339, 1018-1019.
52. Tacke, M., Kiyosawa, K., Stark, K., Schlueter, V., Ofenloch-Haehnle, B., Hess, G. & Engel, A. M. (1997). Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 349, 318-320.
53. Takaki, A., Wiese, M., Maertens, G., Depla, E., Seifert, U., Liebetrau, A., Miller, J. L., Manns, M. P. & Rehermann, B. (2000). Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 6, 578-582.
54. Takikawa, S., Engle, R. E., Faulk, K. N., Emerson, S. U., Purcell, R. H. & Bukh, J. (2010). Molecular evolution of GB virus B hepatitis virus during acute resolving and persistent infections in experimentally infected tamarins. J Gen Virol 91, 727-733.
55. Tan, D., Matsumoto, A., Conry-Cantilena, C., Melpolder, J. C., Shih, J. W., Leuther, M., Hess, G., Gibble, J. W., Ness, P. M. & Alter, H. J. (1999). Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus. J Infect Dis 179, 1055-1061.
56. Tanaka, E., Kiyosawa, K., Shimoda, K., Hino, K., Tacke, M., Schmolke, S., Engel, A. M. & Hess, G. (1998). Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis. J Viral Hepat 5, 153-159.
57. Van der Bij, A. K., Kloosterboer, N., Prins, M., Boeser-Nunnink, B., Geskus, R. B., Lange, J. M., Coutinho, R. A. & Schuitemaker, H. (2005). GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study. J Infect Dis 191, 678-685.
58. Williams, C. F., Klinzman, D., Yamashita, T. E., Xiang, J., Polgreen, P. M., Rinaldo, C., Liu, C., Phair, J., Margolick, J. B. & other authors (2004). Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 350, 981-990.